Advances in management of Thalassemia

Indian Journal of Pediatrics

Volumn 76, Issue 2, 2009, Pages 177-184

  Agarwal, M B ^a,b  

^a BOMBAY HOSPITAL   (India)

^b Haematology Centre   (India)

Author keywords

Anemia; Hemoglobinopathies; Management; Single gene disorder; Thalassemias

Indexed keywords

ALPHA GLOBIN; ASUNRA; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; DESIROX; IRON; LAMIVUDINE; PAMIDRONIC ACID; PEGINTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

ANEMIA; ARTHRITIS; ARTICLE; BONE MARROW TOXICITY; CATARACT; CREATININE BLOOD LEVEL; DRUG DOSE ESCALATION; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL TOXICITY; GENE MUTATION; HEARING LOSS; HEMOGLOBINOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; IRON CHELATION; IRON OVERLOAD; LIVER FIBROSIS; MALARIA; OSTEOPOROSIS; RASH; SIDE EFFECT; THALASSEMIA; ZINC DEFICIENCY;

EID: 63549101289     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-009-0048-7     Document Type: Article

References (14)

1. M.J. Cunningham E.A. Macklin E.J. Newfeld A.R. Cohen 2004 Complications of â-thalassaemia major in North America Blood 104 34 39
2. S.V. De 2002 Growth and puberty and its management in thalassaemia Horm Res 58 Suppl1 72 79
3. L. Hui M.P. Leung S.Y. Ha A.K.T. Chau Y.F. Cheung 2003 Early detection of left ventricular dysfunction in patients with beta thal major by dobutamine stress echocardiography Heart 89 669 670
4. M. Westwood L.J. Anderson D.J. Pennell 2003 Treatment of cardiac iron overload in thalassaemia major (Ed) Haematologica 88 481 482
5. P.D. Jensen 2004 Evaluation of iron overload Br J Haematol 124 697 711
6. R. Fischer F. Longo P. Nielsen R. Engelhardt R.C. Hider A. Piga 2003 Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta thalassaemia major: Application of SQUID biomagnetic liver susceptometry Br J Haematol 121 938 948
7. L.J. Anderson H.B. Davis E. Prescott C.C. Charrier N.H. Bunce D.N. Firmin 2001 Cardiovascular T2-star (T2) magnetic resonance for the early diagnosis of myocardial iron overload Eur Heart J 22 2171 2179
8. P.D. Jensen F.T. Jansen T. Christensen H. Eiskjaer U. Baandrup J.L. Nielsen 2003 Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with desferrioxamine indication of close relation between myocardial iron content and chelation iron pool Blood 101 4632 4639
9. I.R. Wanless G. Sweeney A.P. Dhillon M. Guido A. Piga R. Galanello 2002 Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassaemia Blood 100 1566 1569
10. M.B. Agarwal 2003 ICL 670: A new oral chelator: A major breakthrough in treatment of thalassaemia Ind J Hematol & Bl Trans 31 26 28
11. Y.F. Cheung G.C.F. Chan S.Y. Ha 2002 Arterial stiffness and endothelial function in patients with beta-thalassaemia major Circulation 106 2561 2566
12. E. Voskardou E. Terpos G. Spina J. Palermos A. Rahemtulla A. Loutradi 2003 Pamidronate is an effective treatment for osteoporosis in patients with beta thalassaemia Br J Haematol 123 730 737
13. C. Borgna-Pignatti G. Vergine T. Lombardo 2004 Hepatocellular carcinoma in the thal syndromes Br J Haematol 124 114 117
14. B. Erer G. Lucarelli 1999 Bone marrow transplantation in thalassaemia Turk J Hematol 16 147 159